Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
07/2006
07/19/2006CN1805754A Functionally reconstituted viral membranes containing adjuvant
07/19/2006CN1805753A Treatment of severe acute respiratory syndrome (SARS)
07/19/2006CN1803869A Preparation method of polar group-containing absorptive resin and application thereof in preparation of high-purity sanguinarin
07/19/2006CN1803835A Active polypeptide of brown-spotted torrential frog, its gene and application in drug preparation
07/19/2006CN1803834A Antibacterial peptide of brown-spotted torrential frog, its gene and application in drug preparation
07/19/2006CN1803819A A group of six-carbocycle nucleoside analogue, its synthesis method and antiviral application
07/19/2006CN1803811A Nitro imidazole derivative, its preparation method and uses
07/19/2006CN1803803A Process for preparing ceftezode three-position intermediate
07/19/2006CN1803793A Razole derivatives and application thereof
07/19/2006CN1803787A Hypericum perforatum L. total flavone extracts, its preparation and application
07/19/2006CN1803179A Traditional Chinese medicine composition and its preparation method and quality control method
07/19/2006CN1803168A Traditional Chinese medicine for treating severe acute respiration syndrome (SARS)
07/19/2006CN1803163A Chinese medicine for treating AIDS
07/19/2006CN1803153A Toad essence capsule and its preparation method
07/19/2006CN1803142A Treatment and prophylaxis of diseases and infections of pigs and poultry
07/19/2006CN1803141A Treatment and prophylaxis of diseases and infections of pigs and poultry
07/19/2006CN1803140A Treatment and prophylaxis of diseases and infections of pigs and poultry
07/19/2006CN1803139A Novel medicinal uses of icariin
07/19/2006CN1803138A Cefixime oral disintegration tablet and its preparation method
07/19/2006CN1803136A Preparation method of paracetamol pseudoephedrine hydrochloride and cholrphenamine maleate oral disintegration tablet
07/19/2006CN1264843C Pyrazolopgrimidinone derivatives having PED 7 inhibitory activity
07/19/2006CN1264839C Non-nucleoside reverse transcriptase inhibitors
07/19/2006CN1264837C Antimicrobial quinolones, their compositions and uses
07/19/2006CN1264833C Nonviscous protein type synthetic compound or its carrier combined compound
07/19/2006CN1264573C Method for preparing targeting preparation of human monoclonal antibody crosslinking interferon for anti hepatitis b virus
07/19/2006CN1264572C Fusion protein for treating HBV and its uses
07/19/2006CN1264571C Composite inactivated vaccin for rainbow virus or streptococcus infection and complication thereof of fishes
07/19/2006CN1264568C Virulence genes and proteins, and their use
07/19/2006CN1264555C Process for preparing common arange daylily and Rumex crispus L containing liver-benefiting medicine
07/19/2006CN1264554C Chinese drug composition for treating viral infection of upper respiratory tract and preparing process thereof
07/19/2006CN1264541C Method for producing agrimonia extract with improved activity against hepatitis Bvirus and pharmaceutical and food compositions containing said extract
07/19/2006CN1264540C Acute icterohepatitis treating Chinese traditional medicine and its preparation method
07/19/2006CN1264527C Novel olive kernel leaf extracts and preparation process and medical use thereof
07/19/2006CN1264526C Improved and stable extract from hypericum perforatuml, method for producing and uses as topical medicine
07/19/2006CN1264520C Enteric-coated azithromycin preparation and its preparing process
07/19/2006CN1264517C Application of Netilmicin sulfate in preparation of eye drops
07/19/2006CN1264514C Pediatric formulation of gatifloxacin
07/19/2006CN1264513C Virucidal compositions
07/19/2006CN1264510C Application of geldanamycin (C-3559) preparation of medicine for curing condyloma acuminatum
07/19/2006CN1264508C Arteannuin preparation for treating gynecopathy
07/19/2006CN1264503C Preparnig method for xiao Chaihu effervescent preparation and quality controlling method thereof
07/19/2006CN1264502C Injection of still-freeze drying powder for restoring consciousness and new preparation method
07/18/2006US7078566 Organic acid salts for treating tumor diseases, autoimmune diseases, cardiovascular diseases, infections, and viral diseases; nonsettling by inorganic phosphates, nontoxic to tissue, inhibition of sphingomyelinase
07/18/2006US7078526 Crystal structured fungicides selected from itraconazole, posaconazole or saperconazole used for prevention or prophylaxis of fungi, yeasts and dermatophyte infections
07/18/2006US7078523 Viricides; anticancer agents; immunology moderators
07/18/2006US7078516 Nucleotide sequences derived from the genome of retroviruses of the hiv-1, hiv-2 and siv type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses
07/18/2006US7078492 Human antipneumococcal antibodies from non-human animals
07/18/2006US7078435 Autoinducer compounds
07/18/2006US7078431 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disorders
07/18/2006US7078405 Psychological disorders; anxiolytic agents; dietetics; autoimmune diseases; antidepressants
07/18/2006US7078403 Antiviral agents
07/18/2006US7078402 Sulfur compounds such as S-methyl 4-dimethylamino-4-methyl-2-pentynethioate, used for prophylaxis of cancers, skin disorders or vision defects
07/18/2006US7078399 Antiulcer agents; antiinflammatory agents; therapy for ear infections
07/18/2006US7078398 Compositions and methods for treating or preventing convulsions or seizures
07/18/2006US7078389 Hybridization of a mutagen substituted single-strand nucleic acid molecule with DNA causes a mutation at a specific site; antiproliferative and anticarcinogenic agents; gene therapy
07/18/2006US7078380 comprises vancomycin-type antibiotics; peptide antibiotics; membrane proteins; defensins; for inhibiting peptidoglycan biosynthesis
07/18/2006US7078230 Adipose tissue-derived stromal cell that expresses characteristics of a neuronal cell
07/18/2006US7078223 Preparation of pseudomonic acid A; obtain bacteria capable of producing pseudomonic acid A, culture, ferment and isolate pseudomonic acid A from culture
07/18/2006US7078209 Fused nitrogen heterocyclic compounds; treating fungal diseases
07/18/2006US7078206 for drug screening enzyme inhibitors; by isolating DNA from a patient, amplifying exons by polymerase chain reaction (PCR) and detecting the presence of DNA sequence variation; genetic engineering
07/18/2006US7078196 Genetic engineering ; induction post-transcriptional gene blocking
07/18/2006US7078193 Pathogenic Escherichia coli associated protein espA
07/18/2006US7078173 Assays and therapies for latent viral infection
07/18/2006US7078054 The capsule shell contains a migrateable component (other than glycerol) which is also present in the capsule filling.
07/18/2006US7078052 Enhanced absorption and bioavailability
07/18/2006US7078048 A topical formulation for treating rosacea ( a facial dermatitis ) contains a combination of: an antimicrobial and at least one of non-retinoid inhibitor of one of nuclear factor-k-beta, AP-1 protein, matrix metalloproteinases, CD14
07/18/2006US7078041 Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via same
07/18/2006US7078039 vaccine; inducing immunology response; peptide
07/18/2006US7078038 Gp120 mutants and biological applications
07/18/2006US7078020 Heating antipsychotic drug to vaporize; cooling to form condensation aerosol; kit for dispensing thin coating
07/18/2006US7078019 Heating a drug ester to vaporize; cooling to form condensation aerosol; drug delivery kit for dispensing thin coatings
07/18/2006US7078018 Aerosol therapy; heating, vaporization, cooling, condensation; analgesics; alcoholism
07/18/2006US7078017 Delivery of sedative-hypnotics through an inhalation route
07/18/2006CA2207503C Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpesvirus infections
07/18/2006CA2195556C Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype
07/18/2006CA2152973C Phosphinic acid derivatives, their preparation and their use
07/13/2006WO2006074409A1 Tripeptide and tetrapeptide sulfones
07/13/2006WO2006074317A1 1-thia-2,4a-diaza-cyclopenta[b]naphthalene-3,4-diones and related compounds as anti-infective agents
07/13/2006WO2006074249A1 Tripeptide and tetrapeptide thioethers
07/13/2006WO2006073601A2 Methods and compositions for rna interference
07/13/2006WO2006073172A1 12-oxy-13-amino-containing 16-membered cyclic macrolide derivative and process for producing the same
07/13/2006WO2006073167A1 Pyrrolidine derivatives
07/13/2006WO2006073151A1 Novel fermentation product
07/13/2006WO2006072783A1 Sulfasalazine analogues as nf-kb inhibitors
07/13/2006WO2006072626A1 Kir-binding agents and methods of use thereof
07/13/2006WO2006072579A1 Pharmaceutically active antiviral peptides
07/13/2006WO2006072577A1 Process for preparing granulates comprising amoxicillin
07/13/2006WO2006072562A1 Treatment of hcv disorders
07/13/2006WO2006072370A1 Selected benzofuran derivatives
07/13/2006WO2006072347A2 Alkinyl-substituted thiophenes
07/13/2006WO2006042478A8 Small-molecule inhibitors of coronaviral main protease, their preparation and use
07/13/2006WO2006038116A3 Triazolopyridine derivatives as antibacterial agents
07/13/2006WO2006017468A3 Antibacterial agents
07/13/2006WO2005120475A3 Pharmaceutical composition for the treatment of bacterial infections and sepsis
07/13/2006WO2005074990A3 Methods of preventing and treating sars using low ph respiratory tract compositions
07/13/2006WO2004065367A8 Viral polymerase inhibitors
07/13/2006US20060154976 Reducing the incidence of fibrosis by the co-administration of effective amounts of telmisartan and ramipril; strokes; cardiovascular disorders; organoprotective, tissue-protective, and vasculoprotective effects of combined treatment
07/13/2006US20060154943 Trimethoprim derivative; 5-[6,7-Dimethoxy-2-(7-methoxy-1H-indol-3-ylmethyl)-benzofuran-4-ylmethyl]-pyrimidine-2,4-diamine; potent activity against dihydrofolate reductase, mutated enzyme; superior bioavailability, antibacterial activity; gram positive and negative pathogens
07/13/2006US20060154933 Inhibitors of Cdc25 phosphatases
07/13/2006US20060154928 Novel 2,4-diamino-1,3,5-triazine derivative